Article: LAM Pharmaceuticals' Medical Team to Facilitate Product Training of Chinese Medical Professionals.

LAM Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that the medical team that led the U.S. human study of the LAM IPM Wound Gel is committed to supporting the Company's market entry into China. Welcomed and endorsed by LAM's China distribution partner, the team will work with Sinopharm to ensure Chinese medical professionals, starting with major hospitals in Beijing, Shanghai and Guangzhou, receive proper training regarding the IPM Wound Gel.

Joseph Slechta, President and Chief ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!